ANTINEOVASCULARISATION AGENTS
- aflibercept (YESAFILI, AFLIVU, EYLEA HD, EYLEA)
- brolucizumab (BEOVU)
- faricimab (VABYSMO)
- ranibizumab (RANOPTO, LUCENTIS, BYOOVIZ)
- verteporfin (VISUDYNE)
Using Health Canada Drug Database
updated on 14Sep2025.